Unlocking the Biological Clues of Lung Cancer
Superior Vena Cava Syndrome—A Proposed Classification System and Algorithm for Management
The Insulin-Like Growth Factor Pathway in Lung Cancer
The International Epidemiology of Lung Cancer
Somatic Mutations of the Tyrosine Kinase Domain of Epidermal Growth Factor Receptor and Tyrosine Kinase Inhibitor Response to TKIs in Non-small Cell Lung Cancer: An Analytical Database
Serum Proteomic Profiling of Lung Cancer in High-Risk Groups and Determination of Clinical Outcomes
Comparison of Osteopontin, Megakaryocyte Potentiating Factor, and Mesothelin Proteins as Markers in the Serum of Patients with Malignant Mesothelioma
Lung Perfusion Imaging Can Risk Stratify Lung Cancer Patients for the Development of Pulmonary Complications after Chemoradiation
Waiting Times in Early-Stage Non-small Cell Lung Cancer (NSCLC)
Gaps in Optimal Care for Lung Cancer
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer
Wood-Smoke Exposure as a Response and Survival Predictor in Erlotinib-treated Non-small Cell Lung Cancer Patients
Randomized Multicenter Phase II Study of Larotaxel (XRP9881) in Combination with Cisplatin or Gemcitabine as First-Line Chemotherapy in Nonirradiable Stage IIIB or Stage IV Non-small Cell Lung Cancer
Phase II Study of a 3-Day Schedule with Topotecan and Cisplatin in Patients with Previously Untreated Small Cell Lung Cancer and Extensive Disease
Report of Eight Recent Cases of Locally Advanced Primary Pulmonary Artery Sarcomas: Failure of Doxorubicin-Based Chemotherapy
Erlotinib after Failure of Gefitinib in Patients with Advanced Non-small Cell Lung Cancer Previously Responding to Gefitinib
Superior Vena Cava Syndrome in a Child and Venous Collateral Pathways: MDCT Imaging
Locally Advanced Non-small Cell Lung Cancer: The Past, Present, and Future
Primary Tracheal Lymphoma Causing Respiratory Failure
Differential Diagnosis of Primary Versus Metastatic Pulmonary Adenocarcinomas Using Gene Mutation Analyses
Mucinous Adenocarcinoma of the Thymus
Brief Report: Activity of Imatinib in a Patient with Platelet-Derived-Growth-Factor Receptor Positive Malignant Solitary Fibrous Tumor of the Pleura
Drug Interaction Between Complementary Herbal Medicines and Gefitinib
Too Restrictive Exclusion Criteria in Advanced Stage Lung Cancer Therapeutic Trials: Are We Missing the Target?
Zoledronic Acid and Survival in Patients with Metastatic Bone Disease From Lung Cancer and Elevated Markers of Osteoclast Activity: A Novel Molecular Mechanism
Meeting Announcements